rPCR vs Virgin Plastics: ASTM Data, Super Clean Process, and Berry Global’s Packaging Leadership

Why the rPCR vs virgin plastics debate matters for packaging engineers

As brands accelerate circular economy commitments, engineering teams are asked a tough question: can rPCR recycled plastic reliably match virgin performance in mainstream packaging—especially for food and personal care? Berry Global, a full-portfolio packaging leader (rigid + flexible + nonwovens + closures) with 290+ plants and vertically integrated capabilities from resin to finished goods, has built its answer on data, process control, and scale. The result: high-quality rPCR that approaches virgin performance without compromising safety, supported by FDA approvals and billions of commercial units in market.

In parallel, Berry Global’s dual engine across medical and industrial markets, and its Impact 2025 roadmap, set practical guardrails: 100% of products reusable, recyclable or compostable; Scope 1+2 carbon neutrality by 2030; and ≥30% recycled content across products by 2030. This is not a narrow experiment—it’s an enterprise-level transformation.

ASTM performance data: 50% rPET vs 100% virgin PET

To move beyond opinion, Berry Global commissioned an independent, ASTM-accredited lab to compare a 500 ml carbonated-beverage bottle made with 50% rPET to a 100% virgin PET control. The protocol combined ASTM D2463 mechanical evaluation, ASTM F1927 oxygen transmission, and FDA food-contact migration testing.

Key results (TEST-BERRY-001, April 2024)

• Burst strength at 23°C: 50% rPET averaged 14.2 bar (SD 0.8), virgin averaged 15.1 bar (SD 0.6). The 6% difference is well above typical commercial minimums (>10 bar).
• Drop test from 1.5 m on concrete, filled and capped: 50% rPET achieved 96% pass (48/50 intact), virgin 98% pass (49/50). Both exceed common commercial thresholds (>95%).
• Oxygen permeability (23°C, 50% RH, 24 h): 50% rPET 0.13 cc/bottle/day vs virgin 0.11. Both meet typical carbonated beverage targets (<0.15).
• FDA migration (3% acetic acid, 10 days at 40°C): 50% rPET 3.2 ppm vs virgin 2.8 ppm, both well below the 10 ppm limit.

The takeaway: with high-quality rPCR, performance deltas remained within single digits, while safety benchmarks were comfortably met. In practice, Berry’s 50% rPET bottles performed consistently above requirements across mechanical, barrier, and migration metrics.

Environmental impact at scale

Assuming 1 billion 500 ml bottles at 25 g each, switching from 100% virgin PET to 50% rPET reduces annual emissions by approximately 28,750 tonnes CO2—a ~33% decrease—based on 3.5 kg CO2/kg for virgin PET and ~1.2 kg CO2/kg for rPET. This single product line shift demonstrates why rPCR is central to the circular economy business case.

Inside Berry’s Super Clean process: achieving >99.9% purity and FDA approval

The heart of dependable rPCR performance is contamination control. Berry’s Super Clean process, which has obtained the FDA Letter of No Objection (LNO) for food-contact applications, combines rigorous sourcing with multi-stage decontamination:

• Source control: Predominantly post-consumer PET beverage bottles (PCR) with select post-industrial regrind (PIR), pre-screened to avoid mixed polymers.
• Mechanical preparation: Sorting, grinding, label removal, intensive wash and hot wash to strip organics and adhesives.
• Thermal treatment: High-temperature exposure (~220°C equivalent treatments where relevant) to volatilize and break down residual contaminants.
• Vacuum degassing: Removal of absorbed gases and volatile compounds from the polymer matrix.
• Analytical verification: Routine batch testing to confirm purity (>99.9%) and migration limits (<10 ppm), with nonconforming lots rejected.

In practice, this is the difference between rPCR that is nearly indistinguishable from virgin resin in safety and performance, and lower-quality regrind that can exhibit color shift, odor, or mechanical degradation. Berry’s process is designed to deliver the former, consistently.

Commercial validation: Unilever Dove’s 100% rPCR transformation (2019–2024)

Beyond the lab, Berry Global partnered with Unilever’s Dove brand to transition high-volume HDPE bottles from 25% rPCR to 100% rPCR across five years, ultimately spanning 80+ countries.

Scale and outcomes (CASE-BERRY-001)

• Ramp-up: 2019 pilot at 25% rPCR (10 million bottles) expanded to 50% in 2021, 75% in 2022, and 100% rPCR HDPE in 2023–2024 for most markets.
• Volume: 2024 global rollout covered ~800 million bottles annually (80% of Dove’s volume).
• Material: Ocean Bound Plastic streams (e.g., Indonesia and the Philippines within 50 km of coastlines) incorporated via Super Clean processing to food-grade purity.
• Performance: Quality acceptance rates at 99.5% with consumer complaint rates <0.01%.
• Environmental impact: Cumulative rPCR usage of 120,000 tonnes equates to recycling roughly 6 billion plastic bottles and avoiding ~276,000 tonnes CO2.
• Cost dynamics: Initial premiums of +15% (25% rPCR) evolved to ~+20% at 100% rPCR, buffered by scaling and long-term contracting.
• Market response: Notable brand lift and 2023–2019 sales uptick (~8% increase), with clear on-pack recycled content communication driving positive sentiment.

This case demonstrates technical feasibility, supply stability (zero stock-out events across 40 billion units supplied over five years), and the marketing value of credible recycled content at global scale.

Addressing the performance controversy: what’s true, what’s not

There is a legitimate industry debate about rPCR quality. The balanced view is straightforward: process determines performance.

• Validated performance: Berry’s 50% rPET bottles showed <10% differences vs virgin across burst strength (14.2 vs 15.1 bar), drop test (96% vs 98%), oxygen permeability (0.13 vs 0.11 cc/bottle/day), and FDA migration (3.2 vs 2.8 ppm)—all well within commercial acceptability.
• Food safety: FDA food-contact approvals and batch-level testing substantiate safety. High-quality rPCR is not a compromise on compliance.
• Where problems arise: Lower-quality rPCR without deep decontamination can be inconsistent (gray tint, odor, mechanical variability). This is typically a sourcing and process control issue, not an inherent flaw of rPCR technology.

Berry Global’s stance—and practice across billions of units—is to qualify sources, apply Super Clean decontamination, test every batch, and ensure traceability. This is how rPCR moves from a sustainability label to a repeatable engineering material.

End-to-end advantage: portfolio breadth, vertical integration, and supply-chain agility

rPCR success is not only a resin question; it’s a system question. Berry Global’s breadth across rigid containers (food cans, pharma bottles, personal care bottles), flexibles (stretch, shrink, agricultural films), nonwovens (medical protective apparel, hygiene substrates), and closures (caps, pumps, sprayers), combined with vertical integration from resin (PE/PP/PET) through blow molding, injection molding, extrusion, printing, and assembly, creates a closed loop of accountability and speed.

That integration typically yields a 15–20% cost advantage versus fragmented supply chains, and it underpins rapid response. During COVID-19, Berry scaled U.S. medical protective apparel output from 50,000/day to 5,000,000/day—a 100x increase in ~100 days—delivering 1.5 billion units with zero stock-outs. The same playbook—fast investment, multi-plant conversion, accelerated hiring, and disciplined QA—now applies to rPCR ramp-ups across consumer packaging.

Circular economy economics: policy pressure, market trends, and ROI

The business case for rPCR is reinforced by policy and market dynamics. Joint research by the Ellen MacArthur Foundation and Berry (May 2024) estimates the global rPCR market at $15 billion, growing at ~18% CAGR through 2029, with rPCR share rising from ~10% to ~25% of plastic volumes over that period.

• Policy mandates: EU PPWR requires ≥25% rPET in beverage bottles by 2025 and ≥30% rPCR across all plastic packaging by 2030, with trajectories toward 50% by 2035. U.S. states (CA SB 54, NY, WA) are instituting similar recycled-content thresholds.
• Cost today vs tomorrow: rPCR premiums currently range from ~20–50% depending on resin (with rPP higher), driven by supply constraints and collection/cleaning costs. Berry mitigates this via scale procurement (targeting ~500,000 tonnes/year), multi-year contracts, and investments in advanced/chemical recycling (e.g., a $50 million partnership targeting 100,000 tonnes/year rPET from mixed streams).
• Brand benefits: Beyond compliance, clear recycled-content claims and credible certification boost consumer trust and brand equity. Many brands absorb part of the premium to reduce friction at shelf.

When combined with quantifiable CO2 reductions and risk mitigation against tightening regulations, rPCR becomes not only defensible but advantageous on total ROI.

Implementation playbook: how to qualify rPCR and avoid pitfalls

• Define critical-to-quality specs: Start with burst strength, drop performance, barrier targets, and migration limits aligned to use case.
• Insist on FDA/LNO and batch analytics: Require documentation of purity and migration data; reject nonconforming lots.
• Use multi-layer structures where needed: For color or barrier challenges at high rPCR percentages, deploy co-extruded or molded layers (e.g., rPCR exterior with virgin interior) to balance aesthetics and function.
• Design for circularity: Keep materials mono-polymer when possible, avoid pigments/additives that hinder recyclability, and align with APR design guidelines.
• Pilot, then scale: Start at 25–50% rPCR to stabilize variation, validate consumer acceptance, then progress toward 75–100% with iterative tooling and process adjustments.
• Label transparently: On-pack statements like “Made with Recycled Plastic” increase recognition and reduce the intention–action gap in consumer buying.
• Segment applications: Deploy high-quality rPCR for food, beverage, and personal care packaging; reserve lower-quality streams for non-food industrial uses. Maintain stricter thresholds for infant and direct-contact pharma applications.
• Leverage full-portfolio: Integrate rigid bottles, flexible films, and closures with harmonized recycled content, printing, and assembly to reduce complexity and cost.

Conclusion: high-quality rPCR is ready for mainstream packaging

The evidence is clear: when rPCR is produced via robust decontamination and validated to FDA standards, its performance delta vs virgin can be held within single digits and food safety reliably assured. Berry Global’s Super Clean rPCR, demonstrated in ASTM testing and scaled through the Unilever Dove program (with billions of units supplied and CO2 reductions measured), proves rPCR is not a compromise—it’s a practical, high-impact step toward a circular economy.

For engineering and sustainability teams, the path forward is disciplined and repeatable: qualify the process, lock the specs, scale with integrated manufacturing, and communicate recycled content transparently. With full-portfolio coverage, vertical integration, and a track record in medical and industrial agility, Berry Global is positioned to help brands transition from pilot to mainstream—across rigid and flexible packaging, nonwovens, and closures—while meeting policy mandates and strengthening brand equity.